Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/29/2014US8790934 Nanoparticles
07/29/2014US8790925 Methods of generating hyper iNOS expressing cells and uses thereof
07/29/2014US8790922 RNA sequence-specific mediators of RNA interference
07/29/2014US8790724 Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
07/29/2014US8790723 Eutectic-based self-nanoemulsified drug delivery system
07/29/2014US8790714 Compositions and methods for treatment and prevention of osteoarthritis
07/29/2014US8790702 Modified hyaluronic acid polymer compositions and related methods
07/29/2014US8790700 Modified release formulations containing drug-ion exchange resin complexes
07/29/2014US8790695 Medicinal carriers, and preparation method and uses thereof
07/29/2014US8790694 Gastric retentive extended release pharmaceutical compositions
07/29/2014US8790691 Modified drugs for use in liposomal nanoparticles
07/29/2014US8790689 Tamper resistant transdermal dosage form
07/29/2014US8790687 Triterpene compounds which are effective on improvement of brain function
07/29/2014US8790686 Method and composition for treating hemorrhoids
07/29/2014US8790675 Biocide compositions comprising carbamates
07/29/2014US8790674 Derivative for preparing a topical veterinary pharmaceutical composition for combating external parasites
07/29/2014US8790655 Conjugates of synthetic TLR agonists and uses therefor
07/29/2014US8790654 Glycosylceramide adjuvant for saccharide antigens
07/29/2014US8790646 Compositions and methods for modulating vascular development
07/29/2014US8790634 MetAP-2 inhibitor polymersomes for therapeutic administration
07/29/2014US8790633 Polymer coated magnetic particles
07/29/2014US8790632 Polymer-based tissue-adhesive form medical use
07/29/2014US8790631 Use of biocompatible polymers for the preparation of a composition or a medical device
07/29/2014CA2806767C Patch and method for producing the same
07/29/2014CA2697205C Peptidomimetic protease inhibitors
07/29/2014CA2685845C Liquorice extract antimicrobial and anti-inflammatory isolates
07/29/2014CA2685270C Expression vectors for stimulating an immune response and methods of using the same
07/29/2014CA2677061C Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
07/29/2014CA2673683C Compounds and method for treatment of cancer
07/29/2014CA2667547C Piperidyl-propane-thiol ccr3 modulators
07/29/2014CA2662510C Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy
07/29/2014CA2661819C Fixed combination dosage forms for the treatment of migraine
07/29/2014CA2655398C 4-amino-3-(3-azolyl-phenoxymethyl)-thieno[3,2-c]pyridine-7-carboxylic acid derivatives and uses thereof for treating cancer, atherosclerosis and restenosis
07/29/2014CA2653660C Sulphated hyaluronic acid for treating degenerative osteoarthritis
07/29/2014CA2653223C Therapeutic pyrrolidine compounds
07/29/2014CA2652500C Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
07/29/2014CA2650057C Phenyl- or pyridinyl-amide as inhibitors of c-fms kinase
07/29/2014CA2646942C Improved snuff composition
07/29/2014CA2641421C Small molecule inhibitors of pdz interactions
07/29/2014CA2637768C Benzamide and heteroarene derivatives
07/29/2014CA2637243C Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product
07/29/2014CA2635047C Novel thiophene derivatives as s1p1/edg1 receptor agonists
07/29/2014CA2634743C Modified lysine-mimetic compounds
07/29/2014CA2634701C Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation
07/29/2014CA2627211C Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors
07/29/2014CA2623304C Medicine, food and drink or feed containing sphingomyelin
07/29/2014CA2621273C Stable pharmaceutical composition comprising a pyrimidine-sulfamide
07/29/2014CA2618641C Cyclopropyl compounds and compositions for delivering active agents
07/29/2014CA2611724C Stabilized milnacipran formulation
07/29/2014CA2608631C Method and composition for treating inflammatory disorders
07/29/2014CA2606933C Steroid kit and foamable composition and uses thereof
07/29/2014CA2602328C Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
07/29/2014CA2593993C Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
07/29/2014CA2564603C Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine
07/29/2014CA2562554C Thio-substituted arylmethanesulfinyl derivatives
07/29/2014CA2558112C Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein
07/29/2014CA2555507C Use of proton pump inhibitors for the treatment of cancer conditions
07/29/2014CA2541405C The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
07/29/2014CA2473289C Asymmetric urea compounds useful as naaladase and psma imaging agents
07/29/2014CA2463772C Thrombin-cleavable chimeric proteins
07/29/2014CA2449713C Calcium phosphate delivery vehicles for osteoinductive proteins
07/24/2014WO2014113814A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
07/24/2014WO2014113794A2 Oligooxopiperazines for p53 reactivation
07/24/2014WO2014113784A1 Compounds, extracts and methods from chinese medicinal herb sophora flavescens that inhibit airway contraction
07/24/2014WO2014113750A1 Novel ddp-iv inhibitors
07/24/2014WO2014113700A1 Pharmaceutical compositions comprising nitroxyl donors
07/24/2014WO2014113696A1 Nitroxyl donors with improved therapeutic index
07/24/2014WO2014113675A1 Antiviral compounds and methods of use thereof
07/24/2014WO2014113638A1 Multi-use albuterol maintenance therapy formulations and devices therefor
07/24/2014WO2014113635A1 Reduction of toxicities by synthetic panaxytriol analogs
07/24/2014WO2014113634A1 Toll-like receptor 2-agonistic lipopeptides, and method of making the same
07/24/2014WO2014113616A1 Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and its crystalline
07/24/2014WO2014113609A1 Stable indole-3-propionate salts of s-adenosyl-l-methionine
07/24/2014WO2014113607A1 Protective molecules against anthrax toxin
07/24/2014WO2014113564A1 New itch treatment using a combination of neurokinin-1, gastrin releasing peptide, and glutamate receptor antagonists
07/24/2014WO2014113540A1 A deep intronic target for splicing correction on spinal muscular atrophy gene
07/24/2014WO2014113495A1 Activation or reactivation of ache
07/24/2014WO2014113485A1 Lysophosphatidic acid receptor antagonists
07/24/2014WO2014113467A1 Stat3 inhibitor
07/24/2014WO2014113429A2 Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
07/24/2014WO2014113427A2 Irciniastatin analogues
07/24/2014WO2014113413A1 Bcl-2bcl-xl inhibitors and therapeutic methods using the same
07/24/2014WO2014113406A1 Compositions and methods for treating pancreatic cancer
07/24/2014WO2014113404A1 Treating pulmonary conditions
07/24/2014WO2014113388A1 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
07/24/2014WO2014113377A1 Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant
07/24/2014WO2014113357A1 Combinations of a glp1r agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders
07/24/2014WO2014113303A1 4-fluoropiperidine orexin receptor antagonists
07/24/2014WO2014113260A1 Androgen receptor modulator and uses thereof
07/24/2014WO2014113191A1 Hedgehog pathway signaling inhibitors and therapeutic applications thereof
07/24/2014WO2014113048A1 Compositions and methods for diagnosing and treating sepsis
07/24/2014WO2014112955A1 Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands
07/24/2014WO2014112861A1 An antiviral pharmaceutical composition
07/24/2014WO2014111957A1 Nitric oxide releasing prodrugs of therapeutic agents
07/24/2014WO2014111955A1 Fingolimod containing stable composition
07/24/2014WO2014111954A1 Process for the preparation and purification of apixaban
07/24/2014WO2014111871A1 4,5-dihydroisoxazole derivatives as nampt inhibitors
07/24/2014WO2014111839A1 Pyrrole derivatives as alpha 7 nachr modulators
07/24/2014WO2014111838A1 Use of alpha 7 nicotinic acetylcholine receptor agonists
07/24/2014WO2014111837A1 Use of alpha 7 nicotinic acetylcholine receptor agonists